Fidelity Investments’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-140
| Closed | -$2.05K | – | 5528 |
|
|
2024
Q2 | $2.05K | Sell |
140
-571
| -80% | -$8.35K | ﹤0.01% | 4716 |
|
|
2024
Q1 | $15.9K | Sell |
711
-30
| -4% | -$673 | ﹤0.01% | 4098 |
|
|
2023
Q4 | $14K | Buy |
741
+640
| +634% | +$12.1K | ﹤0.01% | 4117 |
|
|
2023
Q3 | $1.73K | Sell |
101
-240
| -70% | -$4.11K | ﹤0.01% | 4571 |
|
|
2023
Q2 | $10.2K | Buy |
341
+327
| +2,336% | +$9.82K | ﹤0.01% | 4133 |
|
|
2023
Q1 | $396 | Sell |
14
-42
| -75% | -$1.19K | ﹤0.01% | 4818 |
|
|
2022
Q4 | $1.1K | Buy |
56
+48
| +600% | +$943 | ﹤0.01% | 4633 |
|
|
2022
Q3 | $0 | Sell |
8
-55
| -87% | – | ﹤0.01% | 4924 |
|
|
2022
Q2 | $1K | Buy |
63
+43
| +215% | +$683 | ﹤0.01% | 4687 |
|
|
2022
Q1 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 4770 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4416 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4436 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4333 |
|